CN105056234A - 一种光热治疗肿瘤的主动靶向纳米球及其制备方法与应用 - Google Patents
一种光热治疗肿瘤的主动靶向纳米球及其制备方法与应用 Download PDFInfo
- Publication number
- CN105056234A CN105056234A CN201510550751.5A CN201510550751A CN105056234A CN 105056234 A CN105056234 A CN 105056234A CN 201510550751 A CN201510550751 A CN 201510550751A CN 105056234 A CN105056234 A CN 105056234A
- Authority
- CN
- China
- Prior art keywords
- solution
- nanosphere
- dissolved
- active targeting
- take
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000008685 targeting Effects 0.000 title claims abstract description 52
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000011807 nanoball Substances 0.000 title abstract 7
- 239000002105 nanoparticle Substances 0.000 claims abstract description 33
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 27
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims abstract description 19
- 229960003668 docetaxel Drugs 0.000 claims abstract description 19
- 229920001661 Chitosan Polymers 0.000 claims abstract description 17
- 239000006228 supernatant Substances 0.000 claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 16
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960000304 folic acid Drugs 0.000 claims abstract description 15
- 235000019152 folic acid Nutrition 0.000 claims abstract description 15
- 239000011724 folic acid Substances 0.000 claims abstract description 15
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 15
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 15
- 235000019832 sodium triphosphate Nutrition 0.000 claims abstract description 13
- OMZSGWSJDCOLKM-UHFFFAOYSA-N copper(II) sulfide Chemical compound [S-2].[Cu+2] OMZSGWSJDCOLKM-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910021642 ultra pure water Inorganic materials 0.000 claims abstract description 9
- 239000012498 ultrapure water Substances 0.000 claims abstract description 9
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims abstract 5
- 229940069328 povidone Drugs 0.000 claims abstract 5
- 239000002077 nanosphere Substances 0.000 claims description 56
- 239000010949 copper Substances 0.000 claims description 48
- 238000003756 stirring Methods 0.000 claims description 32
- BWFPGXWASODCHM-UHFFFAOYSA-N copper monosulfide Chemical compound [Cu]=S BWFPGXWASODCHM-UHFFFAOYSA-N 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000002244 precipitate Substances 0.000 claims description 16
- 239000011734 sodium Substances 0.000 claims description 16
- 238000007626 photothermal therapy Methods 0.000 claims description 13
- -1 1-ethyl-(3-dimethylaminopropyl) Chemical group 0.000 claims description 8
- 238000013019 agitation Methods 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 238000001291 vacuum drying Methods 0.000 claims description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 125000003929 folic acid group Chemical group 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 210000004881 tumor cell Anatomy 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000000047 product Substances 0.000 abstract description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 abstract 3
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 abstract 2
- 229910052979 sodium sulfide Inorganic materials 0.000 abstract 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 abstract 1
- 238000009395 breeding Methods 0.000 abstract 1
- 230000001488 breeding effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 29
- 210000004027 cell Anatomy 0.000 description 10
- 238000002626 targeted therapy Methods 0.000 description 6
- 238000012377 drug delivery Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 4
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 239000005030 aluminium foil Substances 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 208000035269 cancer or benign tumor Diseases 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000002539 nanocarrier Substances 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 101100150273 Caenorhabditis elegans srb-1 gene Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002088 nanocapsule Substances 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005987 sulfurization reaction Methods 0.000 description 1
- 238000000015 thermotherapy Methods 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510550751.5A CN105056234B (zh) | 2015-09-01 | 2015-09-01 | 一种光热治疗肿瘤的主动靶向纳米球及其制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510550751.5A CN105056234B (zh) | 2015-09-01 | 2015-09-01 | 一种光热治疗肿瘤的主动靶向纳米球及其制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105056234A true CN105056234A (zh) | 2015-11-18 |
CN105056234B CN105056234B (zh) | 2017-12-22 |
Family
ID=54485895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510550751.5A Expired - Fee Related CN105056234B (zh) | 2015-09-01 | 2015-09-01 | 一种光热治疗肿瘤的主动靶向纳米球及其制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105056234B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107007835A (zh) * | 2017-05-31 | 2017-08-04 | 重庆医科大学 | 载普鲁士蓝靶向纳米复合物及其制备方法 |
CN108853494A (zh) * | 2018-05-26 | 2018-11-23 | 西南大学 | 温度触发的载药硫化铜纳米笼的制备方法 |
CN110015679A (zh) * | 2019-04-30 | 2019-07-16 | 上海应用技术大学 | 一种纳米硫化铜的制备方法 |
CN111450848A (zh) * | 2020-05-09 | 2020-07-28 | 青岛科技大学 | CuS纳米点材料的制备方法及其在电催化二氧化碳还原中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103961705A (zh) * | 2014-05-16 | 2014-08-06 | 福州大学 | 叶酸修饰的中空硫化铜/聚多巴胺复合物的制备及其应用 |
CN103990125A (zh) * | 2014-05-30 | 2014-08-20 | 东华大学 | 一种偶联叶酸靶向的空心介孔二氧化硅/硫化铜纳米复合物及其制备和应用 |
-
2015
- 2015-09-01 CN CN201510550751.5A patent/CN105056234B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103961705A (zh) * | 2014-05-16 | 2014-08-06 | 福州大学 | 叶酸修饰的中空硫化铜/聚多巴胺复合物的制备及其应用 |
CN103990125A (zh) * | 2014-05-30 | 2014-08-20 | 东华大学 | 一种偶联叶酸靶向的空心介孔二氧化硅/硫化铜纳米复合物及其制备和应用 |
Non-Patent Citations (1)
Title |
---|
XIALI ZHU ET AL.: "Folic acid mediated solid lipid nanocarriers loaded with docetaxel and oxidized single-walled carbon nanotubes", 《J NANOPART RES》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107007835A (zh) * | 2017-05-31 | 2017-08-04 | 重庆医科大学 | 载普鲁士蓝靶向纳米复合物及其制备方法 |
CN108853494A (zh) * | 2018-05-26 | 2018-11-23 | 西南大学 | 温度触发的载药硫化铜纳米笼的制备方法 |
CN108853494B (zh) * | 2018-05-26 | 2021-05-11 | 西南大学 | 温度触发的载药硫化铜纳米笼的制备方法 |
CN110015679A (zh) * | 2019-04-30 | 2019-07-16 | 上海应用技术大学 | 一种纳米硫化铜的制备方法 |
CN111450848A (zh) * | 2020-05-09 | 2020-07-28 | 青岛科技大学 | CuS纳米点材料的制备方法及其在电催化二氧化碳还原中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105056234B (zh) | 2017-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Electrospun PLA/MWCNTs composite nanofibers for combined chemo-and photothermal therapy | |
CN103768600B (zh) | 一种磁性热敏脂质体纳米金复合物、制备方法及应用 | |
CN108159422A (zh) | 一种自组装载药系统及其复合制剂的制备方法 | |
CN104353075B (zh) | 一种水溶性磁性二氧化钛及其制备方法与应用 | |
CN105056233A (zh) | 具有近红外光热和体内荧光成像特性的多功能介孔二氧化硅纳米粒及其制备方法和应用 | |
CN106039326A (zh) | 一种锆‑卟啉金属有机框架材料的纳米抗癌探针的制备方法 | |
Du et al. | Fabrication of cisplatin-loaded polydopamine nanoparticles via supramolecular self-assembly for photoacoustic imaging guided chemo-photothermal cancer therapy | |
Yang et al. | NIR-activated self-sensitized polymeric micelles for enhanced cancer chemo-photothermal therapy | |
CN105056234A (zh) | 一种光热治疗肿瘤的主动靶向纳米球及其制备方法与应用 | |
CN104758931A (zh) | 一种基于功能化氧化石墨烯温敏水凝胶的制备方法及其应用 | |
CN104368003B (zh) | 一种透明质酸修饰的Au掺杂二氧化钛纳米管的制备方法及其应用 | |
Li et al. | Organic NIR-II dyes with ultralong circulation persistence for image-guided delivery and therapy | |
CN104530256A (zh) | 透明质酸维生素e琥珀酸酯聚合物及其制备和用途 | |
CN105056243A (zh) | 一种透明质酸修饰的磁性中空介孔硫化铜的药物组合物及其制备方法与应用 | |
CN103007281B (zh) | 多机制治疗肿瘤光热控释长循环药物转运系统的制备方法及其应用 | |
CN104940945A (zh) | 一种透明质酸修饰的中空介孔硫化铜复合物及其制备方法与应用 | |
CN105194679A (zh) | 有抗肿瘤药物纳米层的透明质酸修饰的二氧化钛-氧化石墨烯复合材料制备方法及应用 | |
CN105031651B (zh) | 一种酶响应型磁性纳米粒及其制备方法与应用 | |
CN105056244B (zh) | 一种介孔门控型的Fe2+供体与Fe2+依赖性抗肿瘤药物共转运体系及其制备方法与应用 | |
Shinde et al. | Lipid-coated red fluorescent carbon dots for imaging and synergistic phototherapy in breast cancer | |
Xu et al. | Lenvatinib and Cu 2− x S nanocrystals co-encapsulated in poly (d, l-lactide-co-glycolide) for synergistic chemo-photothermal therapy against advanced hepatocellular carcinoma | |
Wang et al. | Tumor microenvironment-responsive polymer with chlorin e6 to interface hollow mesoporous silica nanoparticles-loaded oxygen supply factor for boosted photodynamic therapy | |
Xu et al. | Carbon dots as a promising therapeutic approach for combating cancer | |
Liu et al. | Cascade tumor therapy platform for sensitized chemotherapy and penetration enhanced photothermal therapy | |
Zeng et al. | Current status and prospect of ZIF-based materials for breast cancer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Zhenzhong Inventor after: Zhu Xiali Inventor after: Zhang Yingjie Inventor after: Huang Heqing Inventor after: Hou Lin Inventor after: Zhang Huijuan Inventor after: Li Hongji Inventor before: Zhu Xiali Inventor before: Zhang Yingjie Inventor before: Zhang Zhenzhong Inventor before: Huang Heqing Inventor before: Hou Lin Inventor before: Zhang Huijuan Inventor before: Li Hongji |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 450001 Zhengzhou science and Technology Development Zone, Henan, No. 100 science Avenue Patentee after: Zhengzhou University Address before: 450001 science avenue of Zhengzhou high tech Development Zone, Zhengzhou, Henan Province, No. Patentee before: Zhengzhou University |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171222 Termination date: 20180901 |